Corcept Therapeutics Announces Phase 3 Study Evaluating CORLUX(R) for
Market Wire - the proportion of patients with at least a 50 percent improvement in the Brief Psychiatric Rating Scale Positive Symptom It is more prevalent than either schizophrenia or manic depression. The disorder is characterized by severe depression
Source: www.marketwire.com
Click here for more information about depression medication depression medication
<< Home